glp 1 health insurance GLP-1 drug access and 2026 benefits: What consumers expect New survey data shows 59% of Americans support the Trump administration's plan to broaden access to GLP-1 drugs for weight-loss at discounted Global Health Brief: The rise

"Vitamin B12 and folate status in early pregnancy and cardiometabolic risk factors in the offspring at age 56 years: findings from the ABCD multi-ethnic birth cohort"

Pevec D, et al

October Oct 31: Novartis picked up another indication for Cosentyx Tuesday as the FDA greenlit the IL-17A inhibitor to treat severe hidradenitis suppurativa, a painful, chronic skin condition characterized by boil-like lumps that typically burst into open wounds, leaving lasting scars

They often appear on patients that have a medium or darker skin tone

ClinicalTrials.gov registry FOXO4-DRI search (no registered human trials as of June 2026)

Claritevs BenInsihts enables organizations to visualize and understand their data